New technologies include passive systems that allow for safer injection without altering the caregiver’s administration technique in the hospital and clinical setting.
Formulating oral dosage forms for paediatrics is very challenging due to the specificities of this patient population. Formulators face challenges like ensuring active stability, improving palatability and easing swallowing with specific dosage forms. These issues can be solved with appropriate formulation of attractive dosage forms. Cécile Dusautois of Roquette gives some indications in this article.
The contract research and manufacturing sector is changing to meet the new demands and opportunities that the marketplace presents. Quality, customer care and delivery are baseline expectations, and new demonstration of additional delivered value at the right price is taking centre stage. In this article, Dr Austin McMordie of Almac presents the argument for effective integration as a new way to deliver outsourced services.
Dr Rüdiger Lomb of World Courier explains that “There is no ‘cookie-cutter’ approach to clinical research” and recommends that pharmaceutical practitioners select their service providers with care.
Roger lamb, Healthcare sector Manager at GS1 UK, examines the issue in this in-depth article. The previous success stories of these technologies being implemented show that other healthcare institutions should be following suit to increase efficiency, reduce costs and, most importantly, improve patient safety.
While many believe chemical indicators may fall short of compliance with global regulations and industry best practices, these devices have, over time, migrated to last-mile cold chain applications in the life science market. Jeff Hawkins of Sensitech Inc. explains the considerations for temperature indicator usage.
This article by Dr Manfred Zurkirch of Dividella AG presents a method to measure the environmental impact of different products or services in an analytical way. The LCA method enables the customer to rank packaging solutions and to choose those that help him to reduce his ecological footprint. In general, this environmental ranking goes hand in hand with the economic ranking. In other words, sustainable packaging solutions also save substantial money and can help improve the bottom line of pharmaceutical manufacturers.
The World Health Organization (WHO) currently estimates the global trade in counterfeit drugs to be worth £75 billion, with continued growth predicted to be at a staggering rate of 13% a year. As the counterfeit trade grows, criminals are becoming increasingly sophisticated and capable in the way they package their products. Richard Burhouse of Payne Security explains the global regulatory bodies that have introduced strict legislation to ensure maximum security of pharmaceutical packaging.
Many countries have legislation that requires pharmaceutical and medical device companies to follow good manufacturing practice (GMP) and good distribution practice (GDP) guidelines to ensure the proper production and distribution of medicinal products for human use. In Europe, the EU GDP guidelines (94/C 63/03) offer companies guidance on personnel, documentation, premises and equipment, deliveries to customers, returns and self-inspections. Jim Hardisty of Goplasticpallets.com considers why guidelines fail to address one key element in the distribution process: the use of pallets.
Pharmaceutical packaging manufacturers have become the trailblazers of the packaging world when it comes to ensuring carton quality. In every pharma packaging plant, multiple checks are carried out right through the production process from sales, through design and print, to die-cutting, gluing, and beyond. Yet even this is not enough to ensure the ‘zero fault’ supply that brand owners increasingly require. Jacques Reymond from Bobst explains what carton makers can do from now on.
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
